Accelerated Pharmaceutical Solutions

Products

Information

ICON's Accelerated Pharmaceutical Solutions provide a seamless, end-to-end approach to formulation development and optimisation for small molecules and biologics. Our comprehensive services cover everything from formulation screening and optimisation to analytical method development, validation, and custom packaging, labelling, and distribution—including specialised support for oncology drugs and carbon-14 labelled products.
All Categories
API Contract ManufacturingAnalytical Methods (Biopharmaceutical Services)Development & Validation of Analytical MethodsStability Testing of DrugsChemistry, Manufacturing and Controls (CMC)
Main Categories
Biopharmaceutical ProductsFinished Dosage Forms (Products)Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Biopharmaceutical ServicesContract Research Organisations (CROs) (Services)
ICONICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 39,900 employees in 95 locations in 55 countries as at June 30, 2025. For further information about ICON, visit: www.iconplc.com.

Log in

See all the content and easy-to-use features by logging in or registering!